Search

Your search keyword '"Chang B"' showing total 6,524 results

Search Constraints

Start Over You searched for: Author "Chang B" Remove constraint Author: "Chang B"
6,524 results on '"Chang B"'

Search Results

101. Minimal light requirements and performance under reduced photosynthetic photon flux of GA2ox‐transformed and conventional Kentucky bluegrass.

102. WATER REQUIREMENTS OF FLAX AND MODIFICATION OF THE CROP COEFFICIENT IN THE AGRO-PASTORAL ECOTONE OF CENTRAL INNER MONGOLIA, CHINA.

103. EFFECT OF NITRATE ACID TREATED DOLOMITE ON THE TENSILE PROPERTIES OF ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE (UHMWPE) COMPOSITES.

104. From Integrative to Game-Based Integrative Peer Response: High Ability versus Low Ability

110. Development and validation of a risk prediction model for the recurrence of foot ulcer in type 2 diabetes in China: A longitudinal cohort study based on a systematic review and meta-analysis.

111. Developing Effective Educational Chatbots with ChatGPT prompts: Insights from Preliminary Tests in a Case Study on Social Media Literacy

112. Enhancing Foreign Workers' Online Learning Interaction Strategy: An Action Research in Indonesia Open University

115. Erratum to: Insight into particle production mechanisms via angular correlations of identified particles in pp collisions at s=7 TeV

116. Measurement of the inclusive isolated photon production cross section in pps=7 collisions at pps=7 TeV

117. Event-shape and multiplicity dependence of freeze-out radii in pp collisions at s = 7 TeV

118. Production of muons from heavy-flavour hadron decays in pp collisions at s = 5.02 TeV

119. Measurement of the production of charm jets tagged with D0 mesons in pp collisions at s=7 TeV

120. Energy dependence of exclusive J/ψsNN=5.02 photoproduction off protons in ultra-peripheral p–Pb collisions at J/ψsNN=5.02 TeV

121. Measurement of D0D+D∗+Ds+s=5.02TeV, D0D+D∗+Ds+s=5.02TeV, D0D+D∗+Ds+s=5.02TeV and D0D+D∗+Ds+s=5.02TeV production in pp collisions at D0D+D∗+Ds+s=5.02TeV with ALICE

122. Charged-particle pseudorapidity density at mid-rapidity in p–Pb collisions at sNN = 8.16 TeV

123. Jet fragmentation transverse momentum measurements from di-hadron correlations in s=7sNN=5.02 TeV pp and s=7sNN=5.02 TeV p–Pb collisions

124. Relative particle yield fluctuations in Pb--PbsNN=2.76TeV collisions at Pb--PbsNN=2.76TeV

125. Event-Shape Engineering for the D-meson elliptic flow in mid-central Pb-Pb collisions at sNN=5.02 TeV

126. Study of J/ψ azimuthal anisotropy at forward rapidity in Pb-Pb collisions at sNN=5.02 TeV

127. Noncoding RNAs in chronic obstructive pulmonary disease: From pathogenesis to therapeutic targets

128. Health-Care Utilisation and Costs of Transition from Paliperidone Palmitate 1-Monthly to 3-Monthly Treatment for Schizophrenia: A Real-World, Retrospective, 24-Month Mirror-Image Study

131. Searches for transverse momentum dependent flow vector fluctuations in Pb-Pb and p-Pb collisions at the LHC

133. Erratum to: Production of η mesons up to high transverse momentum in pp collisions at 2.76 TeV

134. Measurement of D-meson production at mid-rapidity in pp collisions at s = 7  TeV

135. Measurement of electrons from beauty-hadron decays in p-Pb collisions at s N N = 2.76 TeV

136. Addendum to: Centrality dependence of high-pT D-meson suppression in Pb-Pb collisions at s N N = 2.76 TeV

137. Production of s NN = 5.02 TeV

138. Energy dependence of forward-rapidity ψ ( 2 S ) production in pp collisions at the LHC

139. Production of η mesons up to high transverse momentum in pp collisions at 2.76 TeV

141. Measurement of azimuthal correlations of D mesons with charged particles in pp collisions at s NN = 5.02  TeV

142. Determination of the event collision time with the ALICE detector at the LHC

143. W and Z boson production in p-Pb collisions at s N N = 5.02 TeV

144. Charged-particle multiplicities in proton–proton collisions at s = 0.9 to 8 TeV

147. Serum Reactive Oxygen Species Modulator 1 as a Novel Predictive Biomarker for Resected Lung Adenocarcinoma: A Retrospective Pilot Study

148. 180O Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: A multicenter, open-label, single-arm, phase II study

Catalog

Books, media, physical & digital resources